PR Newswire December 7, 2021
Dr. Stephen Hahn, former FDA Commissioner and Chief Medical Executive for MD Anderson Cancer Center, becomes CEO
Following three years of research and development, Flagship unveils Harbinger Health with $50 million of committed capital
CAMBRIDGE, Mass., Dec. 7, 2021 /PRNewswire/ — Flagship Pioneering today announced the launch of Harbinger Health, a bioplatform company pioneering the detection of early cancer with a simple blood test that combines Artificial Intelligence (AI) and Machine Learning advances with its recent discoveries about the biology of early cancer. By using this Bio-AI approach to identify cancer before it is visible or symptomatic, Harbinger Health’s proprietary HarbingerHx™ platform has the potential to create an entirely new paradigm for cancer diagnosis, enabling early therapeutic interventions or prevention....
Today's Sponsors
Today's Sponsor